GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » Cyclically Adjusted Revenue per Share

KAINOS Laboratories (TSE:4556) Cyclically Adjusted Revenue per Share : 円1,227.76 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

KAINOS Laboratories's adjusted revenue per share for the three months ended in Dec. 2023 was 円310.120. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円1,227.76 for the trailing ten years ended in Dec. 2023.

During the past 12 months, KAINOS Laboratories's average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of KAINOS Laboratories was 1.40% per year. The lowest was 0.50% per year. And the median was 0.60% per year.

As of today (2024-05-31), KAINOS Laboratories's current stock price is 円1139.00. KAINOS Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円1,227.76. KAINOS Laboratories's Cyclically Adjusted PS Ratio of today is 0.93.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of KAINOS Laboratories was 1.40. The lowest was 0.57. And the median was 0.85.


KAINOS Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for KAINOS Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories Cyclically Adjusted Revenue per Share Chart

KAINOS Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,176.90 1,196.71 1,184.78 1,194.74 1,216.81

KAINOS Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,222.23 1,216.81 1,218.11 1,227.87 1,227.76

Competitive Comparison of KAINOS Laboratories's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's Cyclically Adjusted PS Ratio falls into.



KAINOS Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, KAINOS Laboratories's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=310.12/106.8000*106.8000
=310.120

Current CPI (Dec. 2023) = 106.8000.

KAINOS Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 338.614 95.700 377.889
201406 334.747 98.000 364.806
201409 276.436 98.500 299.730
201412 325.002 97.900 354.548
201503 294.042 97.900 320.773
201506 292.625 98.400 317.605
201509 286.449 98.500 310.586
201512 305.208 98.100 332.275
201603 337.147 97.900 367.797
201606 303.024 98.100 329.898
201609 260.587 98.000 283.987
201612 299.717 98.400 325.303
201703 261.667 98.100 284.873
201706 235.842 98.500 255.715
201709 244.221 98.800 263.996
201712 308.612 99.400 331.587
201803 260.581 99.200 280.545
201806 281.897 99.200 303.494
201809 268.066 99.900 286.581
201812 348.113 99.700 372.903
201903 278.807 99.700 298.662
201906 277.413 99.800 296.871
201909 286.124 100.100 305.275
201912 296.377 100.500 314.956
202003 262.197 100.300 279.189
202006 236.545 99.900 252.883
202009 262.333 99.900 280.452
202012 263.643 99.300 283.556
202103 264.203 99.900 282.451
202106 285.935 99.500 306.913
202109 283.193 100.100 302.148
202112 269.731 100.100 287.785
202203 274.730 101.100 290.219
202206 297.687 101.800 312.308
202209 304.293 103.100 315.213
202212 291.373 104.100 298.930
202303 286.082 104.400 292.659
202306 285.274 105.200 289.613
202309 310.721 106.200 312.476
202312 310.120 106.800 310.120

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


KAINOS Laboratories  (TSE:4556) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

KAINOS Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1139.00/1227.76
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of KAINOS Laboratories was 1.40. The lowest was 0.57. And the median was 0.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


KAINOS Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


KAINOS Laboratories (TSE:4556) Business Description

Traded in Other Exchanges
N/A
Address
38-18, Hongo 2-chome, Bunkyo-ku,, Tokyo, JPN
KAINOS Laboratories, Inc. is focused on development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sale and export/import of physicochemical measuring equipment for medical use.

KAINOS Laboratories (TSE:4556) Headlines

No Headlines